Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Am J Transplant ; 10(9): 1981-90, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20883533

ABSTRACT

Cyclosporin A (CsA), rapamycin (Rapa) and mycophenolic acid (MPA) are frequently used for GVHD prophylaxis and treatment after allogeneic stem cell transplantation (SCT). As NK cells have received great interest for immunotherapeutic applications in SCT, we analyzed the effects of these drugs on human cytokine-stimulated NK cells in vitro. Growth-kinetics of CsA-treated cultures were marginally affected, whereas MPA and Rapa severely prevented the outgrowth of CD56(bright) NK cells. Single-cell analysis of NK cell receptors using 10-color flow cytometry, revealed that CsA-treated NK cells gained a similar expression profile as cytokine-stimulated control NK cells, mostly representing NKG2A(+) KIR(-) NCR(+) cells. In contrast, MPA and Rapa inhibited the acquisition of NKG2A and NCR expression and NK cells maintained an overall NKG2A(-) KIR(+) NCR(+/-) phenotype. This was reflected in the cytolytic activity, as MPA- and Rapa-treated NK cells, in contrast to CsA-treated NK cells, lost their cytotoxicity against K562 target cells. Upon target encounter, IFN-γ production was not only impaired by MPA and Rapa, but also by CsA. Overall, these results demonstrate that CsA, MPA and Rapa each have distinct effects on NK cell phenotype and function, which may have important implications for NK cell function in vivo after transplantation.


Subject(s)
Cyclosporine/administration & dosage , Cytotoxicity, Immunologic/drug effects , Immunosuppressive Agents/administration & dosage , Killer Cells, Natural/physiology , Mycophenolic Acid/pharmacology , Phenotype , Sirolimus/administration & dosage , CD56 Antigen/blood , CD56 Antigen/classification , Cell Proliferation/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Humans , Interferon-gamma/biosynthesis , Killer Cells, Natural/cytology , Killer Cells, Natural/drug effects , NK Cell Lectin-Like Receptor Subfamily C/metabolism , Receptors, Natural Killer Cell/metabolism , Tissue Distribution
2.
FASEB J ; 21(10): 2323-34, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17431094

ABSTRACT

Dendritic cells (DCs) and natural killer (NK) cells are essential components of the innate immunity and play a critical role in the first phase of host defense against infection. Interactions between DCs and NK cells have been demonstrated in a variety of settings, with evidence emerging of complex bidirectional crosstalk between the two cell types. The accessory HIV-1 Nef protein is a crucial determinant for viral replication and pathogenesis. We previously demonstrated that Nef, hijacking DC functional activity, subverts the DC arm of immune response to escape the adaptive immune attack. Here, we monitor the effect of Nef on the outcome of the innate immune response, focusing on the impact of Nef on DC/NK crosstalk. We demonstrate that Nef up-regulates the ability of DCs to stimulate the immunoregulatory NK cells (CD56(bright)) as assessed by the activated phenotype, up-regulation of their proliferative response and INF-gamma release. On the other hand, Nef-pulsed DCs inhibit cytotoxic NK cells (CD56(dim)), as assessed by the reduced HLA-DR surface expression, reduced proliferation and cytotoxic activity. Moreover, in the presence of Nef-pulsed DCs, we found a significant up-regulation of TNF-alpha secretion and a significant reduction of IL-10, GM-CSF, MIP-1alpha and RANTES secretion. Our findings suggest that the Nef-induced dysregulation in the DC/NK cell crosstalk may represent a potential mechanism through which HIV escapes innate immune surveillance.


Subject(s)
CD56 Antigen/physiology , Dendritic Cells/immunology , Gene Products, nef/pharmacology , Killer Cells, Natural/immunology , Acquired Immunodeficiency Syndrome/immunology , CD56 Antigen/classification , CD56 Antigen/drug effects , Cell Division , Dendritic Cells/drug effects , Dendritic Cells/virology , Flow Cytometry , Gene Products, nef/physiology , Granulocyte-Macrophage Colony-Stimulating Factor/metabolism , Humans , Interleukin-10/metabolism , Killer Cells, Natural/drug effects , Killer Cells, Natural/virology , Recombinant Proteins/pharmacology , Virus Replication/physiology , nef Gene Products, Human Immunodeficiency Virus
SELECTION OF CITATIONS
SEARCH DETAIL